Portfolio Holdings Detail for ISIN IE000OHHIBC6
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Core MSCI World UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerIWDD.AS(USD) CXE
ETF TickerIWDD(USD) Euronext Amsterdam

Holdings detail for TEVA

Stock NameTeva Pharma Industries Ltd ADR
TickerTEVA(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS8816242098
LEI549300BAFGM4RC74ZJ94

Show aggregate TEVA holdings

News associated with TEVA

Medincell Reports Positive Phase 3 Safety Data For Olanzapine LAI; No PDSS Observed
(RTTNews) - Medincell SA (MEDCL.PA) reported that new long-term safety data from the completed Phase 3 SOLARIS trial support the potential of Olanzapine LAI (TEV-749) as the first long-acting olanzapine treatment option for schizophrenia, with no post-injection delirium/sedation - 2025-09-22 03:59:28
HEFA, EFA, TEVA, MNDY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Currency Hedged MSCI EAFE ETF (Symbol: HEFA) where we have detected an approximate $98.6 million dollar outflow -- that's a 1.5% decrease we - 2025-09-19 11:50:18
Tuesday's ETF with Unusual Volume: EFG
The iShares MSCI EAFE Growth ETF is seeing unusually high volume in afternoon trading Tuesday, with over 10.5 million shares traded versus three month average volume of about 647,000. Shares of EFG were down about 0.5% on the day. Components of that ETF with the highest volume - 2025-09-16 13:25:58
Noteworthy ETF Inflows: IDEV, CYBR, TEVA, CCEP
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI International Developed Markets ETF (Symbol: IDEV) where we have detected an approximate $366.0 million dollar inflow -- that's a 1 - 2025-09-08 12:03:35
Notable ETF Inflow Detected - IXUS, AER, TEVA, FUTU
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $129.6 million dollar inflow -- that's a 0.3% in - 2025-08-25 13:46:54
Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters
Key PointsQuarterly-filed Form 13Fs give investors a way to track which stocks Wall Street's best money managers are buying and selling. - 2025-08-20 04:51:00
US Bancorp DE Has $166,000 Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
US Bancorp DE lifted its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 6.5% in the first quarter, HoldingsChannel reports. The firm owned 10,812 shares of the company’s stock after purchasing an additional 656 shares during the period. US Bancorp DE’s holdings in Teva Pharmaceutical Industries were worth $166,000 at the end […] - 2025-08-17 05:46:51
Deutsche Bank AG Increases Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Deutsche Bank AG grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 16.9% in the 1st quarter, HoldingsChannel reports. The firm owned 2,589,607 shares of the company’s stock after buying an additional 375,064 shares during the quarter. Deutsche Bank AG’s holdings in Teva Pharmaceutical Industries were worth $39,802,000 as of its […] - 2025-08-13 05:18:59
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.71 Consensus PT from Analysts
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price […] - 2025-08-04 02:43:01
Wall Street Zen Upgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Buy
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. TEVA has been the subject of a number of other reports. JPMorgan Chase & Co. upgraded Teva Pharmaceutical Industries from a “neutral” rating […] - 2025-07-28 04:02:50
Signaturefd LLC Trims Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Signaturefd LLC decreased its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 28.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,768 shares of the company’s stock after selling 2,739 shares during the period. Signaturefd LLC’s holdings in […] - 2025-07-22 07:20:51
Head to Head Comparison: Teva Pharmaceutical Industries (NYSE:TEVA) vs. Taysha Gene Therapies (NASDAQ:TSHA)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Profitability This table compares Taysha Gene […] - 2025-07-22 02:45:38
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters
Key PointsForm 13Fs provide investors with an over-the-shoulder look at which stocks Wall Street's brightest money managers are buying and selling. - 2025-07-18 04:06:00
Bank of New York Mellon Corp Sells 11,648 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Bank of New York Mellon Corp lessened its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,609,696 shares of the company’s stock after selling 11,648 shares during […] - 2025-07-17 04:32:51
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 5.7% during the first quarter, HoldingsChannel reports. The firm owned 1,921,762 shares of the company’s stock after selling 116,779 shares during the period. Envestnet Asset Management Inc.’s holdings in Teva Pharmaceutical Industries were worth $29,537,000 at the end […] - 2025-07-15 05:14:50
DekaBank Deutsche Girozentrale Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
DekaBank Deutsche Girozentrale decreased its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,127 shares of the company’s stock after selling 1,453 shares during the period. DekaBank Deutsche Girozentrale’s […] - 2025-07-14 05:34:47
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.13 Consensus Price Target from Analysts
Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) have earned a consensus rating of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […] - 2025-07-10 02:50:52
GAMMA Investing LLC Sells 3,068 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
GAMMA Investing LLC trimmed its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 41.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,390 shares of the company’s stock after selling 3,068 shares during the […] - 2025-07-09 04:24:51
Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) saw some unusual options trading activity on Monday. Stock investors purchased 59,369 put options on the stock. This is an increase of approximately 93% compared to the typical volume of 30,826 put options. Teva Pharmaceutical Industries Stock Down 1.0% TEVA stock opened at $16.84 on Tuesday. […] - 2025-07-08 02:20:24
Retirement Systems of Alabama Makes New Investment in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Retirement Systems of Alabama acquired a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 401,249 shares of the company’s stock, valued at approximately $6,167,000. Other large investors […] - 2025-06-25 05:08:59
IXUS, TEVA, TME, MNDY: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $593.1 million dollar inflow -- that's a 1.3% in - 2025-06-20 12:07:30
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.
QRG Capital Management Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 12.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,430 shares of the company’s stock after selling 18,708 shares during […] - 2025-06-20 05:38:53
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
There's nothing more valuable on Wall Street than data, and investors rarely have to dig to find something that's pertinent to the U.S. economy, the stock market, or their specific portfolio holdings. - 2025-06-16 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of “Buy” by Brokerages
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been given a consensus rating of “Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average […] - 2025-06-12 05:30:57
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Large Increase in Short Interest
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 38,700,000 shares, an increase of 36.1% from the April 30th total of 28,430,000 shares. Based on an average trading volume of 12,300,000 […] - 2025-06-04 05:04:50
Monday's ETF with Unusual Volume: EFAA
The Invesco MSCI EAFE Income Advantage ETF is seeing unusually high volume in afternoon trading Monday, with over 217,000 shares traded versus three month average volume of about 30,000. Shares of EFAA were down about 0.1% on the day. Components of that ETF with the highest vo - 2025-06-02 14:56:10
B. Riley Wealth Advisors Inc. Buys New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
B. Riley Wealth Advisors Inc. bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,689 shares of the company’s stock, valued at approximately $214,000. Other hedge funds and other institutional […] - 2025-06-02 05:40:56
Teva Pharmaceutical Industries (NYSE:TEVA) Now Covered by Truist Financial
Truist Financial assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $25.00 price target on the stock. TEVA has been the topic of several other reports. Barclays reduced their price target on Teva Pharmaceutical Industries from […] - 2025-05-29 03:14:53
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
The amount of data investors digest daily on Wall Street can sometimes feel overwhelming. Over the last six weeks, investors have navigated their way through earnings season, a Federal Reserve Open Market Committee meeting, and President Donald Trump's regularly changing tariff a - 2025-05-28 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Recommendation of “Buy” from Analysts
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price […] - 2025-05-23 06:58:47

iShares Core MSCI World UCITS ETF USD (Dist) TEVA holdings

DateNumber of TEVA Shares HeldBase Market Value of TEVA SharesLocal Market Value of TEVA SharesChange in TEVA Shares HeldChange in TEVA Base ValueCurrent Price per TEVA Share HeldPrevious Price per TEVA Share Held
2026-02-09 (Monday)1,699,564USD 58,583,971TEVA holding decreased by -373904USD 58,583,9710USD -373,904 USD 34.47 USD 34.69
2026-02-06 (Friday)1,699,564TEVA holding increased by 9972USD 58,957,875TEVA holding decreased by -1056433USD 58,957,8759,972USD -1,056,433 USD 34.69 USD 35.52
2026-02-02 (Monday)1,689,592USD 60,014,308TEVA holding increased by 2433013USD 60,014,3080USD 2,433,013 USD 35.52 USD 34.08
2026-01-30 (Friday)1,689,592USD 57,581,295TEVA holding increased by 1706488USD 57,581,2950USD 1,706,488 USD 34.08 USD 33.07
2026-01-29 (Thursday)1,689,592USD 55,874,807TEVA holding increased by 912379USD 55,874,8070USD 912,379 USD 33.07 USD 32.53
2026-01-27 (Tuesday)1,689,592USD 54,962,428TEVA holding increased by 658941USD 54,962,4280USD 658,941 USD 32.53 USD 32.14
2026-01-26 (Monday)1,689,592USD 54,303,487TEVA holding increased by 557565USD 54,303,4870USD 557,565 USD 32.14 USD 31.81
2026-01-23 (Friday)1,689,592USD 53,745,922TEVA holding increased by 253439USD 53,745,9220USD 253,439 USD 31.81 USD 31.66
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TEVA by Blackrock for IE000OHHIBC6

Show aggregate share trades of TEVA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY9,972 34.690* -
2026-01-15BUY952 32.350* -
2026-01-14BUY2,380 32.640* -
2026-01-08BUY2,856 32.510* -
2026-01-07BUY1,666 32.400* -
2026-01-06BUY2,16032.80931.560 31.685USD 68,439 -
2026-01-05BUY2,61831.09030.490 30.550USD 79,980 -
2025-12-19SELL-2,84430.56029.890 29.957USD -85,198 -
2025-12-17BUY5,45130.20529.875 29.908USD 163,029 -
2025-12-16BUY94830.42029.840 29.898USD 28,343 -
2025-12-15BUY1,18530.44029.700 29.774USD 35,282 -
2025-12-12BUY1,35630.13029.560 29.617USD 40,161 -
2025-12-08BUY1,89628.74028.000 28.074USD 53,228 -
2025-12-03BUY2,85627.90026.840 26.946USD 76,958 -
2025-12-02BUY71427.07026.530 26.584USD 18,981 -
2025-11-18BUY1,20025.07024.220 24.305USD 29,166 -
2025-11-10BUY96024.50023.980 24.032USD 23,071 -
2025-11-07BUY1,68024.42023.610 23.691USD 39,801 -
2025-11-06BUY1,21024.88023.870 23.971USD 29,005 -
2025-11-04BUY7,29020.72020.110 20.171USD 147,047 -
2025-11-03BUY5,12420.88020.305 20.363USD 104,337 -
2025-10-31BUY2,97620.60019.975 20.038USD 59,632 -
2025-10-30BUY73520.38020.005 20.042USD 14,731 -
2025-10-29BUY2,20520.23020.619 20.581USD 45,380 -
2025-10-24BUY2,70618.95019.190 19.166USD 51,863 -
2025-10-20BUY1,70819.42019.450 19.447USD 33,215 -
2025-10-17BUY2,20519.31019.690 19.652USD 43,333 -
2025-10-03BUY1,69420.01020.610 20.550USD 34,812 -
2025-10-01BUY1,70120.06020.460 20.420USD 34,734 -
2025-09-26SELL-10,69218.34018.700 18.664USD -199,555 -
2025-09-18BUY1,94418.45018.660 18.639USD 36,234 -
2025-09-04BUY3,87218.48018.800 18.768USD 72,670 -
2025-08-21BUY74118.80018.830 18.827USD 13,951 -
2025-08-20BUY1,23017.61017.630 17.628USD 21,682 -
2025-08-18BUY98818.06018.280 18.258USD 18,039 -
2025-08-06BUY3,47216.01016.110 16.100USD 55,899 -
2025-08-05BUY5,20815.71015.920 15.899USD 82,802 -
2025-08-04BUY4,00015.69015.780 15.771USD 63,084 -
2025-08-01BUY99215.38015.450 15.443USD 15,319 -
2025-07-31BUY1,96015.45016.920 16.773USD 32,875 -
2025-07-30BUY1,71516.83017.240 17.199USD 29,496 -
2025-07-29BUY2,69516.54016.660 16.648USD 44,866 -
2025-07-23BUY2,20516.58016.690 16.679USD 36,777 -
2025-07-22BUY1,22516.29016.380 16.371USD 20,054 -
2025-07-18BUY74116.06016.490 16.447USD 12,187 -
2025-07-16BUY98416.01016.100 16.091USD 15,834 -
2025-07-14BUY1,71516.42016.740 16.708USD 28,654 -
2025-07-11BUY98016.40016.430 16.427USD 16,098 -
2025-07-09BUY1,46416.71017.070 17.034USD 24,938 -
2025-07-08BUY73216.63016.880 16.855USD 12,338 -
2025-07-07BUY1,94416.85017.100 17.075USD 33,194 -
2025-07-02BUY4,37417.05017.140 17.131USD 74,931 -
2025-06-30BUY6,05016.76016.950 16.931USD 102,433 -
2025-06-18BUY1,68017.06017.300 17.276USD 29,024 -
2025-06-04BUY4,76017.52017.660 17.646USD 83,995 -
2025-06-03BUY71117.19017.360 17.343USD 12,331 -
2025-05-16BUY96816.94017.220 17.192USD 16,642 -
2025-05-09BUY1,19516.93018.250 18.118USD 21,651 -
2025-05-06BUY1,44016.12016.710 16.651USD 23,977 -
2025-04-30BUY98815.51015.620 15.609USD 15,422 -
2025-04-25BUY2,41014.87014.900 14.897USD 35,902 -
2025-04-24BUY1,92814.72014.770 14.765USD 28,467 -
2025-04-23BUY96414.29014.610 14.578USD 14,053 -
2025-04-17BUY1,47613.65013.740 13.731USD 20,267 -
2025-04-16BUY1,96813.43013.640 13.619USD 26,802 -
2025-04-15BUY4,18213.60013.800 13.780USD 57,628 -
2025-04-14BUY1,72913.60013.830 13.807USD 23,872 -
2025-04-11BUY4,16513.46013.460 13.460USD 56,061 -
2025-04-10BUY97612.82013.950 13.837USD 13,505 -
2025-04-09BUY6,09814.16014.330 14.313USD 87,281 -
2025-04-08SELL-39413.59014.410 14.328USD -5,645 -
2025-04-07SELL-1,21013.94014.550 14.489USD -17,532 -
2025-04-04BUY1,45813.80014.530 14.457USD 21,078 -
2025-03-31BUY6,77615.37015.530 15.514USD 105,123 -
2025-03-27BUY1,44015.49015.800 15.769USD 22,707 -
2025-03-26BUY4,78015.69015.750 15.744USD 75,256 -
2025-03-24BUY1,19516.18016.280 16.270USD 19,443 -
2025-03-19BUY2,14216.29016.570 16.542USD 35,433 -
2025-03-17BUY4,04616.71016.890 16.872USD 68,264 -
2025-03-11BUY2,86816.10016.220 16.208USD 46,485 -
2025-03-07BUY71415.36015.460 15.450USD 11,031 -
2025-03-05BUY2,85615.90016.130 16.107USD 46,002 -
2025-03-04BUY1,90415.69016.060 16.023USD 30,508 -
2025-02-26BUY96416.78017.130 17.095USD 16,480 -
2025-02-25BUY1,68716.61016.860 16.835USD 28,401 -
2025-02-24BUY1,67316.78016.920 16.906USD 28,284 -
2025-02-18BUY6,72016.57017.150 17.092USD 114,858 -
2025-02-14BUY1,43416.25016.630 16.592USD 23,793 -
2025-02-13BUY2,39016.63016.740 16.729USD 39,982 -
2025-02-12BUY1,91216.34016.490 16.475USD 31,500 -
2025-02-10BUY72016.81017.120 17.089USD 12,304 -
2025-02-06BUY72017.29017.580 17.551USD 12,637 -
2025-02-05BUY1,42217.21017.520 17.489USD 24,869 -
2025-02-04BUY1,65917.06017.580 17.528USD 29,079 -
2025-01-31BUY71117.73018.320 18.261USD 12,984 -
2024-12-30BUY1,41022.32022.530 22.509USD 31,738 -
2024-12-27BUY1,88022.77022.800 22.797USD 42,858 -
2024-12-20BUY1,41622.09022.170 22.162USD 31,381 -
2024-12-18BUY95621.20021.980 21.902USD 20,938 -
2024-12-17BUY3,58520.88021.050 21.033USD 75,403 -
2024-12-16BUY43416.51016.830 16.798USD 7,290 -
2024-12-13BUY9,06616.50016.860 16.824USD 152,526 -
2024-12-11BUY6,18817.45017.550 17.540USD 108,538 -
2024-12-10BUY4,99817.35017.640 17.611USD 88,020 -
2024-12-09BUY3,80817.60017.760 17.744USD 67,569 -
2024-12-06BUY2,61817.33017.860 17.807USD 46,619 -
2024-12-05BUY4,52217.82018.020 18.000USD 81,396 -
2024-12-04BUY1,92817.80018.250 18.205USD 35,099 -
2024-12-03BUY3,85617.53017.790 17.764USD 68,498 -
2024-12-02BUY4,78016.65016.870 16.848USD 80,533 -
2024-11-29BUY4,30216.78016.960 16.942USD 72,884 -
2024-11-27BUY1,90416.57016.690 16.678USD 31,755 -
2024-11-26BUY5,47416.59016.670 16.662USD 91,208 -
2024-11-25BUY47616.69017.060 17.023USD 8,103 -
2024-11-21BUY1,92017.08017.170 17.161USD 32,949 -
2024-11-20BUY3,12017.03017.160 17.147USD 53,499 -
2024-11-19BUY2,16016.81016.860 16.855USD 36,407 -
2024-11-18BUY7,64216.49016.500 16.499USD 126,085 -
2024-11-11BUY3,09417.37017.510 17.496USD 54,133 -
2024-11-08BUY2,14217.11017.500 17.461USD 37,401 -
2024-11-07BUY2,37017.50017.860 17.824USD 42,243 -
2024-11-06BUY1,18517.43019.310 19.122USD 22,660 -
2024-11-05BUY3,79218.77018.790 18.788USD 71,244 -
2024-11-01BUY3,55518.45018.730 18.702USD 66,486 -
2024-10-31BUY1,90418.44018.470 18.467USD 35,161 -
2024-10-30BUY1,19018.59018.740 18.725USD 22,283 -
2024-10-29BUY1,74018.43018.480 18.475USD 32,146 -
2024-10-28BUY1,90418.37018.400 18.397USD 35,028 -
2024-10-21BUY1,90418.18018.410 18.387USD 35,009 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TEVA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,326,5673,9412,847,92146.6%
2025-09-181,947,0074,4264,674,64341.7%
2025-09-171,292,03911,6644,003,06232.3%
2025-09-162,251,05334,1784,868,20946.2%
2025-09-152,578,4201,1006,567,43639.3%
2025-09-122,617,2923,8615,387,05448.6%
2025-09-111,863,29620,5674,067,64945.8%
2025-09-102,057,02820,4195,058,82940.7%
2025-09-092,177,3481,4526,082,56535.8%
2025-09-082,198,38610,5265,200,40442.3%
2025-09-051,747,0799,4934,271,66740.9%
2025-09-042,087,4506,8304,093,85851.0%
2025-09-032,032,2261,6005,035,50140.4%
2025-09-022,391,6341,6546,813,17335.1%
2025-08-291,374,4768,9783,008,16845.7%
2025-08-281,177,4872,9463,118,00237.8%
2025-08-271,884,3936,5553,323,17156.7%
2025-08-261,914,1803,2494,260,23844.9%
2025-08-251,407,4634203,321,52342.4%
2025-08-222,604,23506,684,84039.0%
2025-08-213,825,58611,3899,899,00138.6%
2025-08-201,144,0974,8783,530,09532.4%
2025-08-191,739,2672,5246,118,13828.4%
2025-08-181,882,6078,5925,438,37334.6%
2025-08-152,099,82311,0134,305,31648.8%
2025-08-142,419,7941,7065,478,47244.2%
2025-08-131,584,58814,9394,845,26532.7%
2025-08-121,591,6691,5003,589,46744.3%
2025-08-111,671,9143,2004,204,80939.8%
2025-08-082,394,84705,125,37046.7%
2025-08-072,680,05910,9546,786,02139.5%
2025-08-062,688,426464,2865,933,92345.3%
2025-08-052,444,3624035,927,09541.2%
2025-08-042,580,27015,6067,333,66035.2%
2025-08-012,963,212367,2567,094,54541.8%
2025-07-313,200,20711,2499,684,59433.0%
2025-07-304,694,4888,58111,845,32239.6%
2025-07-292,050,8484,0847,443,23327.6%
2025-07-282,220,328596,554,15633.9%
2025-07-251,667,7231,2824,447,67237.5%
2025-07-241,993,9982,3594,968,34340.1%
2025-07-231,911,52610,6915,766,86233.1%
2025-07-221,643,6011354,872,10033.7%
2025-07-211,325,4748003,789,65035.0%
2025-07-181,955,50155,942,64232.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy